Gritstone Oncology Announces FDA Fast Track Designation for GRANITE-001 for the Treatment of Colorectal Cancer Portfolio News / By admin December 20, 2018
Carmot Therapeutics Initiates Phase 1 Trial to Treat Type 2 Diabetes Portfolio News / By admin December 19, 2018
Gritstone Oncology Announces Publication in Nature Biotechnology of Neoantigen Identification Capabilities of its Artificial Intelligence Platform, EDGE™ Portfolio News / By admin December 17, 2018
Gritstone Oncology Advances Solid Tumor Bispecific Antibody Program into Lead Optimization Phase; Appoints Vice President of Antibody Therapeutics to Spearhead Portfolio News / By admin December 10, 2018
Constellation Pharmaceuticals Initiates Phase 2 Portion of ProSTAR Clinical Trial in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Portfolio News / By admin December 10, 2018
Kallyope Inc. Announces $21 Million Expansion of Series B Financing Portfolio News / By admin December 5, 2018